Hemodialysis and Peritoneal Dialysis Market is Predicted to Reach US$ 132.16 million by 2027 Registering a CAGR of 22.1% -Baxter International, B. Braun Melsungen, Diaverum , Nipro Corporation, Nxstage Medical, Davita Healthcare Partners, Fresenius Medica

The global hemodialysis and peritoneal dialysis market size was valued at USD 88.16 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.61% from 2022 to 2030. Rising incidence of Acute Kidney Injury (AKI), shortage of organ donors, risks associated with transplants, technological advancements, and initiatives by the leading players to introduce advanced products and services are a few factors driving the demand for hemodialysis and peritoneal dialysis, thereby propelling the market growth. In addition, the outbreak of the COVID-19 pandemic has resulted in a significant demand for dialysis across the world. Owing to this, the market has witnessed regulatory support from various government authorities and a rise in financial incentives. These factors are expected to contribute to the positive growth of the market during the forecast period.

The Hemodialysis and Peritoneal Dialysis report is highly structured into a region-wise study. The regional analysis comprehensively done by the researchers highlights key regions and their dominating countries accounting for substantial revenue share in the market. The study helps understand how the market will fare in the respective region, while also mentioning the emerging regions growing with a significant CAGR.

Download FREE Sample Report @ https://www.mraccuracyreports.com/report-sample/551337

The report provides a comprehensive analysis of company profiles listed below:

Baxter International, B. Braun Melsungen, Diaverum , Nipro Corporation, Nxstage Medical, Davita Healthcare Partners, Fresenius Medical Care, Mar Cor Purification, Asahi Kasei Medical

Hemodialysis and Peritoneal Dialysis Market Types:

Dialyzer, Catheter, Transfer Kit.

Hemodialysis and Peritoneal Dialysis Market Applications:

Hospital, Household

Type Insights
In 2021, the hemodialysis segment dominated the market with a revenue share of over 85.0% and is expected to expand at the highest CAGR during the forecast period. In addition, the hemodialysis segment is further fragmented into conventional, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is further sub-segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis (APD). The rising number of ESRD patients, a surge in the geriatric population suffering from kidney diseases, and the rising prevalence of diabetes and hypertension are significant factors driving the segment. According to World Population Ageing 2020 report, there were an estimated 727 million people aged 65 years or over worldwide. The portion of the populace is projected to more than double by 2050, reaching over 1.5 billion persons. An aging population and a rising risk of CKD are projected to significantly boost the segment growth.

Buy Exclusive Report@: https://www.mraccuracyreports.com/checkout/551337

End-use Insights
In 2021, the hospital-based segment dominated the market with a share of over 80.0%. The segment is likely to maintain its lead in the coming years because of the significant availability of highly qualified and experienced healthcare personnel in the hospitals. The presence of a professional and experienced renal care team ensures optimal treatment and enhanced dialysis results in healthcare settings such as dialysis centers and hospitals. In addition, the growing focus of players on building independent dialysis centers and the high adoption of patients for the treatment in in-center dialysis are some of the factors projected to drive the segment. Moreover, companies are focusing on the development of customized hemodialysis machines with a variety of interventions. This is likely to have an influence on the end-user experience.

Get Up to 30% Discount on the first purchase of this report @ https://www.mraccuracyreports.com/check-discount/551337

Regional Insights
North America dominated the market with the largest revenue share of over 35.0% in 2021. The presence of key participants, significant investments by governments for the development of innovative medical devices, and the presence of a favorable reimbursement scenario are supplementing the growth of the market in the region. Due to the rising incidence of kidney failures and Chronic Kidney Diseases (CKD), there is increasing demand for dialysis. Increasing healthcare spending, government initiatives, and high disposable income are a few other factors contributing to the market growth.

The Asia Pacific region is estimated to register the highest CAGR of 7.6% over the forecast period. Over the forecast period, rising incidences of kidney failure, the growing geriatric population, and the augmented development of advanced products are expected to support market growth. Furthermore, as per the IDF, in South East Asia, around 88 million adults are living with diabetes and the number is expected to increase to 153 million by 2045. Moreover, increasing healthcare spending, rising government initiatives, awareness campaigns regarding CKD, technologically enhanced products, and the presence of newly-established state-of-the-art healthcare facilities in the region are a few other factors contributing to market growth.

#Customization Service of the Report:

Mr Accuracy Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Call Us - UK +44 7452119323
USA +1 8045001224
Email us - sales@mraccuracyreports.com
30 Crawley Lane, West Sussex, RH10 7EG, United Kingdom
3351 Green Turtle Rd, Regina, SK S4V 3N6, Canada

MR Accuracy Reports is a Market Research and consulting company that accomplishes requirement of research agencies,small, medium and large corporations, global business leaders, government organizations,
SME's, Individual & Start-ups, top management consulting firms

This release was published on openPR.